Search results
Author(s):
Akshyaya Pradhan
,
Monika Bhandari
,
Pravesh Vishwakarma
,
et al
Added:
2 years ago
Author(s):
Dariusz Dudek
,
Jacek Legutko
,
Roman Wojdyła
,
et al
Added:
3 years ago
Thrombectomy for patients with ST elevation myocardial infarction (STEMI) is an evolving issue. Randomised studies on suction and thrombectomy devices in a whole spectrum of STEMI patients provide conflicting results. New European Society of Cardiology (ESC) percutaneous coronary intervention (PCI) guidelines do not give definitive recommendations regarding the use of embolic protection devices…
View more
Author(s):
Dariusz Dudek
,
Jacek Legutko
,
Roman Wojdyła
,
et al
Added:
3 years ago
Thrombectomy for patients with ST elevation myocardial infarction (STEMI) is an evolving issue. Randomised studies on suction and thrombectomy devices in a whole spectrum of STEMI patients provide conflicting results. New European Society of Cardiology (ESC) percutaneous coronary intervention (PCI) guidelines do not give definitive recommendations regarding the use of embolic protection devices…
View more
Author(s):
Ashkan Shoamanesh
Added:
1 year ago
ESC Congress 22 — Prof Ashkan Shoamanesh (McMaster University, CA) reveals the findings of the PACIFIC-STROKE trial (NCT04304508). This multicenter study aims to find the best dose of oral FXIa inhibitor, asundexian (Bayer). 1808 patients with non-cardioembolic ischemic stroke were included in this trial, and were randomized to receive different doses of asundexian.
Questions:
What doses were…
View more
Kurt Huber
Job title: Head of the 3rd Med. Dept. of Cardiology and Internal Intensive Care Medicine
Author
Author(s):
Rainer Moosdorf
Added:
3 years ago
Pulmonary embolism is mainly caused by deep venous thrombosis in the lower extremities, mostly due to longer immobilisation and/or restricted venous backflow. Thus, most patients have a typical history; however, symptoms may be misinterpreted and therapy delayed. While smaller or fragmented thrombi in the peripheral segments of the pulmonary arteries may only cause dyspnoea and hardly any…
View more
Sahlén Anders Olof
Author
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
4 years ago
Prof Nicolas Van Mieghem & Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) give their analysis of the late-breaking trials from AHA 2019.
View more
Author(s):
Jan Steffel
Added:
6 years ago
Utility of remotely managed patient clinical and diagnostic markers to effect better outcomes - Jan Steffel from Zurich, Switzerland presenting from EHRA 2017.
View more